Insider Selling: Omada Health (NASDAQ:OMDA) President Sells $90,618.34 in Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 5,618 shares of the firm’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the completion of the transaction, the president owned 69,079 shares in the company, valued at approximately $1,114,244.27. The trade was a 7.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Omada Health Stock Up 2.9%

Shares of NASDAQ:OMDA opened at $15.78 on Friday. The company has a market cap of $913.79 million and a PE ratio of -63.12. Omada Health, Inc. has a fifty-two week low of $14.14 and a fifty-two week high of $28.40. The firm has a 50-day simple moving average of $18.77 and a 200 day simple moving average of $20.00.

Analyst Upgrades and Downgrades

OMDA has been the subject of a number of analyst reports. Evercore ISI boosted their price objective on Omada Health from $27.00 to $28.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. Baird R W upgraded shares of Omada Health to a “hold” rating in a research report on Friday, September 5th. Morgan Stanley set a $32.00 price objective on shares of Omada Health in a research report on Thursday, December 18th. Finally, Robert W. Baird initiated coverage on shares of Omada Health in a research report on Friday, September 5th. They issued a “neutral” rating and a $24.00 target price for the company. Eight equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.11.

Institutional Investors Weigh In On Omada Health

Several institutional investors have recently bought and sold shares of OMDA. Cigna Investments Inc. New acquired a new position in Omada Health during the 3rd quarter valued at about $76,161,000. Perceptive Advisors LLC bought a new position in shares of Omada Health in the second quarter valued at approximately $44,402,000. Divisadero Street Capital Management LP acquired a new position in shares of Omada Health during the third quarter valued at approximately $30,510,000. Loomis Sayles & Co. L P bought a new stake in Omada Health during the second quarter worth approximately $19,948,000. Finally, BIT Capital GmbH acquired a new stake in Omada Health in the third quarter worth approximately $13,639,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.